141 related articles for article (PubMed ID: 16611636)
1. Activity-based protein profiling implicates urokinase activation as a key step in human fibrosarcoma intravasation.
Madsen MA; Deryugina EI; Niessen S; Cravatt BF; Quigley JP
J Biol Chem; 2006 Jun; 281(23):15997-6005. PubMed ID: 16611636
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasion.
Conn EM; Botkjaer KA; Kupriyanova TA; Andreasen PA; Deryugina EI; Quigley JP
Am J Pathol; 2009 Oct; 175(4):1638-52. PubMed ID: 19729488
[TBL] [Abstract][Full Text] [Related]
3. Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.
Deryugina EI; Zijlstra A; Partridge JJ; Kupriyanova TA; Madsen MA; Papagiannakopoulos T; Quigley JP
Cancer Res; 2005 Dec; 65(23):10959-69. PubMed ID: 16322244
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
[TBL] [Abstract][Full Text] [Related]
5. Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.
Bekes EM; Deryugina EI; Kupriyanova TA; Zajac E; Botkjaer KA; Andreasen PA; Quigley JP
Neoplasia; 2011 Sep; 13(9):806-21. PubMed ID: 21969814
[TBL] [Abstract][Full Text] [Related]
6. Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation.
Conn EM; Madsen MA; Cravatt BF; Ruf W; Deryugina EI; Quigley JP
J Biol Chem; 2008 Sep; 283(39):26518-27. PubMed ID: 18658134
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
8. In-vivo imaging of tumor associated urokinase-type plasminogen activator activity.
Hsiao JK; Law B; Weissleder R; Tung CH
J Biomed Opt; 2006; 11(3):34013. PubMed ID: 16822063
[TBL] [Abstract][Full Text] [Related]
9. The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.
Tsuchiya H; Katsuo S; Matsuda E; Sunayama C; Tomita K; Ueda Y; Binder BR
Gen Diagn Pathol; 1995 May; 141(1):41-8. PubMed ID: 8542506
[TBL] [Abstract][Full Text] [Related]
10. Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination.
Juncker-Jensen A; Deryugina EI; Rimann I; Zajac E; Kupriyanova TA; Engelholm LH; Quigley JP
Cancer Res; 2013 Jul; 73(14):4196-211. PubMed ID: 23687338
[TBL] [Abstract][Full Text] [Related]
11. A novel mode of intervention with serine protease activity: targeting zymogen activation.
Blouse GE; Bøtkjaer KA; Deryugina E; Byszuk AA; Jensen JM; Mortensen KK; Quigley JP; Andreasen PA
J Biol Chem; 2009 Feb; 284(7):4647-57. PubMed ID: 19047064
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator (uPA) and its receptor (CD87): a new target in tumor invasion and metastasis.
Schmitt M; Wilhelm O; Jänicke F; Magdolen V; Reuning U; Ohi H; Moniwa N; Kobayashi H; Weidle U; Graeff H
J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):151-65. PubMed ID: 8556577
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
18. Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism.
Donet M; Brassart-Pasco S; Salesse S; Maquart FX; Brassart B
Br J Cancer; 2014 Jul; 111(1):139-48. PubMed ID: 24874477
[TBL] [Abstract][Full Text] [Related]
19. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
Biliran H; Sheng S
Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
[TBL] [Abstract][Full Text] [Related]
20. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
